Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
about
The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.A narrative review of the potential for self-tanning products to substitute for solaria use among people seeking a tanned appearance.Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model.Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.
P2860
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@en
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@nl
type
label
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@en
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@nl
prefLabel
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@en
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@nl
P2093
P2860
P1433
P1476
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
@en
P2093
Michael E Nelson
Sean M Bryant
Steven E Aks
P2860
P304
P356
10.3109/15563650.2012.740637
P407
P577
2012-11-05T00:00:00Z